ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer: coexpression, clinical significance, and prognostic value.

Diagn Pathol · 2026 · PMC12895697 · PMID 41555342

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

Furthermore, combining the expression levels of ESM1 and Pan-kla allowed for highly significant stratification of ovarian cancer patients into four distinct risk strata with markedly different prognoses (overall P < 0.001, Fig. 3 C).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.